Renal Cancer - Results from #5560

A four-gene promoter methylation marker panel consisting of GREM1, NEURL, LAD1 and NEFH predicts survival of clear cell renal cell cancer patients October 28, 2016

Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma October 28, 2016

Clinical Usage of Different Guidelines in Routine Management, Therapy and Follow-Up of Patients with Renal Cell Cancer in Germany October 28, 2016

Effective induction of cytotoxic T cells recognizing an epitope peptide derived from hypoxia-inducible protein 2 (HIG2) in patients with metastatic renal cell carcinoma October 27, 2016

Bevacizumab and wound-healing complications: a systematic review and meta-analysis of randomized controlled trials October 27, 2016

Prognostic role of the cumulative toxicity in patients affected by metastatic renal cells carcinoma and treated with first-line tyrosine kinase inhibitors October 27, 2016

Calcified synovial metastasis in the knee from renal cell carcinoma: a case report October 26, 2016

Endoscopic ultrasound-guided fine needle aspiration cytology of metastatic renal cell carcinoma to the pancreas: A multi-center experience October 26, 2016

Clinical significance of sunitinib-associated macrocytosis in metastatic renal cell carcinoma October 26, 2016

Neuropeptide Levels as well as Neprilysin Activity Decrease in Renal Cell Carcinoma October 25, 2016

Malignancy rates and diagnostic performance of the Bosniak classification for the diagnosis of cystic renal lesions in computed tomography - a systematic review and meta-analysis October 25, 2016

Postoperative Outcome of Cystic Renal Cell Carcinoma Defined on Preoperative Imaging: A Retrospective Study October 24, 2016

Immunohistochemistry Successfully Uncovers Intratumoral Heterogeneity and Widespread Co-Losses of Chromatin Regulators in Clear Cell Renal Cell Carcinoma October 24, 2016

Prognostic Significance of CD24 in Clear Cell Renal Cell Carcinoma October 21, 2016

MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patients October 21, 2016

Clinical Pharmacokinetics and Pharmacodynamics of Cabozantinib October 20, 2016

Axitinib after Sunitinib in Metastatic Renal Cancer: Preliminary Results from Italian "Real-World" SAX Study October 20, 2016

Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach October 18, 2016

Analysis of the Abscopal Effect With Anti-PD1 Therapy in Patients With Metastatic Solid Tumors October 18, 2016

Meta-analysis of gene expression and integrin-associated signaling pathways in papillary renal cell carcinoma subtypes October 14, 2016

Page 279 of 460